MIST Milestone Pharmaceuticals Inc
Company Analysis
Latest News
🔴 Milestone Pharmaceuticals is trading 15.75% down in pre-market ahead of Q2 2026 results on August 12
Milestone Pharmaceuticals is trading 15.75% down at $1.07 ahead of its scheduled second-quarter 2026 financial-results release before the market open on August...
Milestone Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Milestone Pharmaceuticals is expected to report a Q2 2026 loss of $0.18 per share on revenue of $1.85 million, with the current $2.45 stock price trading...
🟢 Milestone Pharmaceuticals is trading 6.2% up today amid a broad-market rally
Milestone Pharmaceuticals is trading 6.2% up today at $1.19 as the stock moves in line with a broad-market rally and improved investor risk appetite. • Major...
🔴 Milestone Pharmaceuticals is trading 5.2% down today on profit-taking and sector weakness
Milestone Pharmaceuticals is trading 5.2% down at $1.09 today, retracing after a sharp 10.6% gain in the previous session despite a lack of new...
🟢 Milestone Pharmaceuticals is trading 10.6% up today alongside broader market rally
Milestone Pharmaceuticals is trading 10.6% higher at $1.15 today, moving in tandem with a strong broader U.S. equity rally despite a lack of company-specific...
🟢 Milestone Pharmaceuticals is trading 5.8% up today with no clear company news
Milestone Pharmaceuticals is trading 5.8% up today at $1.13 on light company-specific news flow. • No fresh filings, press releases, trial updates, or analyst...
🔴 Milestone Pharmaceuticals is trading 6.6% down today as it gives back recent pre-market gains
Milestone Pharmaceuticals is trading at $1.05 (6.6% down) today, giving back a portion of its recent pre-market strength in the absence of fresh...
🟢 Milestone Pharmaceuticals is trading 6.9% up today with no clear catalyst
Milestone Pharmaceuticals is trading at $1.24 (+6.88%) in pre-market sessions with no clear company-specific catalyst found in available news. • The stock's...
🟢 Milestone Pharmaceuticals is trading 5.7% up today as traders reassess last week's post-earnings selloff
Milestone Pharmaceuticals is trading at $1.25 (5.7%) up today as shares stage a recovery following a significant selloff triggered by last week's Q1 earnings...
🟢 Milestone Pharmaceuticals is trading 6.2% up today on a rebound from post-earnings weakness
Milestone Pharmaceuticals is trading at $1.29 (6.2%) up today, rebounding after recent selling pressure tied to its Q1 earnings miss and CARDAMYST revenue...
🔴 MIST is trading 5% down today following Q1 earnings miss and CARDAMYST revenue disappointment
MIST is trading 5% down today at $1.23 as the stock continues to drift lower following its May 13 Q1 earnings miss and major CARDAMYST revenue...
🟢 MIST is trading 5.4% up today as it rebounds from a prior Q1 earnings-driven selloff
MIST is trading at $1.36 (5.4% up) in after-hours trading, rebounding modestly from recent pressure following its May 13, 2026, Q1 earnings miss and revenue...